Frances Burlin

Frances Burlin
Name	Frances Burlin
Nationality	American
Fields	Molecular biology, Genetics
Workplaces	National Institutes of Health, Stanford University
Alma mater	University of California, Berkeley, Massachusetts Institute of Technology
Known for	Gene regulation, Epigenetics
Awards	Lasker Award, National Medal of Science

Frances Burlin. An American molecular biologist and geneticist renowned for her pioneering research into the mechanisms of gene regulation and epigenetics. Her work, primarily conducted at the National Institutes of Health and later at Stanford University, fundamentally advanced the understanding of how eukaryotic cells control genetic expression. Burlin's discoveries have had profound implications for the fields of developmental biology, cancer research, and genetic engineering.

Early life and education

Born in San Francisco, she demonstrated an early aptitude for the sciences, which was nurtured by her teachers at Lowell High School. She pursued her undergraduate studies at the University of California, Berkeley, where she majored in biochemistry and conducted research on bacterial plasmids. For her doctoral work, Burlin attended the Massachusetts Institute of Technology, joining the laboratory of James D. Watson where she investigated transcription in bacteriophage systems. Her postdoctoral fellowship was completed at the Cold Spring Harbor Laboratory, focusing on early Drosophila melanogaster development under the mentorship of Eric Wieschaus.

Career

Burlin began her independent research career as an investigator at the National Institutes of Health in Bethesda, Maryland. After establishing a prominent laboratory there, she was recruited by the Department of Genetics at Stanford University, where she served as a professor for over two decades. During her tenure, she also held visiting professorships at the University of Cambridge and the Weizmann Institute of Science. Burlin served on numerous advisory boards, including for the Howard Hughes Medical Institute and the National Science Foundation, and was a key figure in shaping the Human Genome Project.

Research and contributions

Burlin's most significant contributions centered on the chromatin remodeling complexes that regulate access to DNA. Her laboratory identified a key family of ATP-dependent enzymes, later named the SWI/SNF complex, which alters nucleosome positioning to activate gene expression. This work provided a direct mechanistic link between chromatin structure and transcriptional regulation. Subsequently, her team made groundbreaking discoveries in epigenetics, elucidating how DNA methylation and specific histone modifications, such as histone acetylation, create a heritable "code" that dictates cellular identity without altering the underlying DNA sequence. These findings were critical for understanding phenomena like genomic imprinting and X-inactivation.

Awards and honors

In recognition of her transformative research, Burlin received numerous prestigious awards. She was a co-recipient of the Albert Lasker Award for Basic Medical Research and was awarded the National Medal of Science by President Bill Clinton. She was elected to the National Academy of Sciences, the American Academy of Arts and Sciences, and was a foreign member of the Royal Society. Other notable honors include the Wolf Prize in Medicine, the Gairdner Foundation International Award, and the Pearl Meister Greengard Prize.

Personal life

She was married to David Baltimore, a fellow Nobel laureate in Physiology or Medicine, and they collaborated on several studies concerning retrovirus gene expression. An avid supporter of the arts, she served on the board of the San Francisco Symphony and was a dedicated collector of Modernist paintings. Burlin was also known for her commitment to mentoring young scientists, particularly women in STEM fields, and advocated for increased funding for basic scientific research through testimony before the United States Congress.

Legacy

Frances Burlin's work established foundational principles in epigenetics and gene regulation that continue to guide contemporary biomedical research. Her discoveries directly informed new therapeutic strategies, including the development of histone deacetylase inhibitors for cancer treatment. The techniques and conceptual frameworks developed in her laboratory remain standard in molecular biology labs worldwide. Her legacy is perpetuated through the numerous scientists she trained, many of whom now lead major research programs at institutions like Harvard University, the California Institute of Technology, and the Max Planck Institute.

Category:American molecular biologists Category:American geneticists Category:National Medal of Science recipients